Preferences of Type 1 Diabetic Patients on Devices for Islet Transplantation.

ABSTRACT: Transplantation of pancreatic islets within a biomaterial device is currently under investigation in clinical trials for the treatment of patients with type 1 diabetes (T1D). Patients' preferences on such implants could guide the designs of next-generation implantable devices; however, such information is not currently available. We surveyed the preferences of 482 patients with T1D on the size, shape, visibility, and transplantation site of islet containing implants. More than 83% of participants were willing to receive autologous stem cells, and there was no significant association between implant fabricated by one's own stem cell with gender (χ² (1, n = 468) = 0.28; P = 0.6) or with age (χ² (4, n = 468) = 2.92; P = 0.6). Pre

SUBMITTER: Mohammadi MR 

PROVIDER: S-EPMC7784499 | biostudies-literature | 2020 Jan-Dec

REPOSITORIES: biostudies-literature